A Retrospective Analysis of Treatment of Covid-19 with Favipiravir
, , , , , , e
13 lug 2022
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 13 lug 2022
Pagine: 74 - 78
Ricevuto: 22 lug 2021
Accettato: 11 mag 2022
DOI: https://doi.org/10.2478/jbcr-2022-0010
Parole chiave
© 2022 Sholpan A. Kulzhanova et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Kulzhanova, Sholpan A.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Konkayeva, Maiya E.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Smagulova, Zauresh K.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Beisenbieva, Nazira N.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Tuleshova, Gulnara T.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Utegenova, Aigul M.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Turebaeva, Gulsimzhan O.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan
Nurakhmetova, Gaukhar A.
NJSC “Astana Medical University”Nur-Sultan, Kazakhstan